The myelotoxicity of carboplatin is influenced by the time of its administration
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.
1987 • 385 citations
Circadian Timing of Cancer Chemotherapy
1985 • 358 citations
Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
1984 • 304 citations
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
1984 • 242 citations
Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
1977 • 217 citations
The clinical application of chronobiology to oncology
1983 • 59 citations
Selected Aspects of Cisplatin Nephrotoxicity in the Rat and Man
1984 • 13 citations
Pharmacokinetics ofcis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (iproplatinum, chip) in patients with normal and impaired renal function and following intraperitoneal administration
1988 • 2 citations